Articles From: ACE Reports Fourth Quarter Operating Income of $824 Million or $2.39 Per Share, Up 67%, P&C Net Premiums Written up 20% in Constant Dollars, and Operating Return on Equity of 12.1% to AcelRx Pharmaceuticals to Participate at the 26th Annual Roth Conference


2014/1/28
ACE Limited (NYSE: ACE) today reported net income for the quarter ended December 31, 2013, of $2.90 per share, compared with $2.22 per share for the same quarter last year.
Sign-up for ACE Reports Fourth Quarter Operating Income of $824 Million or $2.39 Per Share, Up 67%, P&C Net Premiums Written up 20% in Constant Dollars, and Operating Return on Equity of 12.1% investment picks
ACE Limited (NYSE: ACE) today reported net income for the quarter ended September 30, 2013, of $2.66 per share, compared with $1.86 per share for the same quarter last year.
Sign-up for ACE Reports Record Quarterly Operating Income of $857 Million; Global P&C Net Premiums up over 10.5% in Constant Dollars; P&C Underwriting Income up 67% with P&C Combined Ratio of 86.5%; Operating Return on Equity is 13% investment picks
2013/9/3
ACE Risk Management®, the primary casualty division of ACE USA, today announced that it has enhanced its award winning ACE Accelerator SM program, which allows users to electronically sign their state UM/UIM coverage election forms.
Sign-up for ACE Risk Management Enhances ACE Accelerator, A Solution for Documentation of Uninsured and Underinsured Motorists Coverage investment picks
ACE USA, the U.S.-based retail operations of ACE Group, today announced that ACE Risk Management, the company’s primary casualty division, has again earned top honors in the 2013 Business Insurance Buyers Choice Awards.
Sign-up for ACE Risk Management Receives Three Buyers Choice Awards from Business Insurance Magazine investment picks
By Cynthia Koons Insurer ACE Limited (ACE) reached a conditional agreement to take a 60.9% stake in the general-insurance division of Siam Commercial Bank (SCB.TH) for $185 million, ACE said on Monday.
Sign-up for ACE to Acquire Majority of Siam Commercial Bank's Non-Life Insurance Business investment picks
The ACE Group today announced it will release the results of an industry-wide survey on construction safety conducted by Advisen and sponsored by ACE during the annual IRMI Construction Risk Conference to be held in San Diego, CA on November 18, 2013.
Sign-up for ACE USA and Advisen Ltd. to Release Results of Construction Safety Survey at the 33rd IRMI Construction Risk Conference investment picks
ACE USA, the U.S. based retail operations of ACE Group, today announced the appointment of Aaron Turner in the newly-created dual role of Vice President, Managed Care and Business Development, Life Sciences.
Sign-up for ACE USA Appoints Aaron Turner Vice President, Managed Care and Business Development, in Medical Risk & Life Sciences Business investment picks
ACE USA, the U.S. based retail operations of ACE Group, today announced the appointment of Carl Sutter as Senior Vice President, Distribution Management.
Sign-up for ACE USA Appoints Carl Sutter Senior Vice President, Distribution Management investment picks
ACE USA, the U.S. based retail operations of ACE Group, today announced the appointment of Kimberly Springer as Branch Manager of its Kansas City branch office.
Sign-up for ACE USA Appoints Kimberly Springer as Kansas City Branch Manager investment picks
2013/10/28
ACE USA, the U.S. based retail operations of the ACE Group, today announced key executive appointments in its regional operations.
Sign-up for ACE USA Makes Executive Appointments in Regional Operations investment picks
The ACE Group today announced that Caroline Clouser, Executive Vice President and Practice Leader, and Diane Doherty, Vice President, both of ACE Medical Risk Group, will participate in a session with Dick Sem, President and CEO of Sem Security Management, discussing the emerging risk of violence in hospitals.
Sign-up for ACE USA’s Caroline Clouser and Diane Doherty to Participate in Panel on Violence in Hospitals: A Growing Workplace Epidemic at the ASHRM 2013 Annual Conference investment picks
The ACE Group today announced Jon Peeples, Vice President, ACE Environmental Risk and Frank Westfall, Vice President, ESIS, Inc., Health Safety and Environmental Services, will participate in a session with Paul Fox, Risk Manager, of Texas Christian University, discussing updates and recommendations on how to implement the OSHA Hazard Communication Standard.
Sign-up for ACE USA’s Jon Peeples and ESIS’ Frank Westfall to participate in a Panel Session on Hazard Communication Standard 2013: A Transition Guide for Educators at the URMIA 2013 Annual Conference investment picks
ACE Westchester, the U.S.-based wholesale-focused operation of the ACE Group today announced the appointment of Jim Norman as Senior Vice President & Manager, ACE Westchester Inland Marine.
Sign-up for ACE Westchester Appoints Jim Norman Senior Vice President & Manager, Inland Marine investment picks
2014/1/23
ACE Group today announced the ACE Women’s Forum (AWF) and the Professional Women’s Roundtable (PWR) will be co-hosting a panel discussion on the current political climate on January 24, from 8-10 a.m. at ACE’s Philadelphia headquarters, 436 Walnut Street.
Sign-up for ACE Women’s Forum and the Professional Women’s Roundtable to Host a Political Panel investment picks
2013/9/24
The American Council of Engineering Companies (ACEC) of Massachusetts has awarded Tighe & Bond its prestigious Gold Award for its work at the Town of Sturbridge, MA wastewater treatment plant using an innovative combination of Siemens Water Technologies BioMag ® and CoMag ® Systems .
Sign-up for ACEC Awards Tighe & Bond for Plant Upgrade with Innovative Siemens BioMag® and CoMag® Water Treatment Systems investment picks
2013/12/16
- FDA establishes the PDUFA action date of July 27, 2014 for Zalviso - - Conference Call Scheduled Monday, December 16th 2013 for 8:30 a.m. Eastern Time - REDWOOD CITY, Calif.
Sign-up for AcelRx and Grunenthal Announce Collaboration for EU Commercialization of ZALVISO™ investment picks
2013/12/11
REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Adds New Board Member investment picks
First medical meeting data presentations from Phase 3 clinical trial conducted in orthopedic surgery patients REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Announces Data Presentations for Zalviso™ at US and International Medical Meetings investment picks
2014/3/25
REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer investment picks
- 30 mcg sufentanil NanoTab treatment group experienced rapid onset of action with statistically significant pain relief and reduced pain intensity at 30 minutes - REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data at Anesthesia Medical Conference investment picks
Patent estate includes nine issued U.S. patents, nineteen patents worldwide REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso™ and its Proprietary Platform Technologies investment picks
2014/3/3
REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results investment picks
2013/8/12
REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results investment picks
2013/11/5
REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Reports Third Quarter 2013 Financial Results investment picks
2013/9/30
Zalviso NDA submitted for the management of moderate-to-severe acute pain in adult patients in the hospital setting REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Submits New Drug Application to the FDA for Zalviso™ investment picks
2013/8/2
REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013 investment picks
2013/10/22
REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals to Hold Third Quarter 2013 Financial Results Conference Call and Webcast on November 5, 2013 investment picks
2014/3/7
REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals to Participate at the 26th Annual Roth Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: ACE Reports Fourth Quarter Operating Income of $824 Million or $2.39 Per Share, Up 67%, P&C Net Premiums Written up 20% in Constant Dollars, and Operating Return on Equity of 12.1% to AcelRx Pharmaceuticals to Participate at the 26th Annual Roth Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity